SMTL ID : 4tv3.1

Isolated p110a subunit of PI3Ka provides a platform for structure-based drug design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

monomer

Ligands

1 x ML9: 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one(Non-covalent)

ML9.1: 19 residues within 4Å: Chain A: R.668, M.670, W.678, I.698, K.700, L.705, D.708, Y.734, I.746, E.747, V.748, V.749, S.752, T.754, M.756, Q.757, M.820, I.830, D.831 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:W.678, A:Y.734, A:I.746, A:V.749, A:T.754, A:I.830 Hydrogen bonds: A:R.668, A:K.700, A:V.749, A:V.749, A:Q.757, A:D.831

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, P. et al., Engineering of an isolated p110 alpha subunit of PI3K alpha permits crystallization and provides a platform for structure-based drug design. Protein Sci. (2014)

Release Date

2014-08-06

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Related Entries With Identical Sequence